For most of agricultural history, livestock pain was either denied ("animals don't feel pain like we do") or accepted as an unavoidable aspect of farming ("it's just part of the process"). Castration, dehorning, branding, mulesing, and other painful procedures were performed routinely without anesthesia or analgesia, and disease-related pain was largely untreated. This situation began changing in the 1980s–1990s as veterinary pain science advanced and as animal welfare science demonstrated that livestock do experience significant pain with welfare consequences.
By 2025, the scientific case for livestock pain management is overwhelming. The practical and regulatory frameworks are catching up, though significant gaps remain between the evidence base and routine practice.
All domesticated livestock species (cattle, pigs, sheep, goats, horses, poultry, and fish) have the neuroanatomical structures necessary for pain perception: nociceptors, afferent nerve fibers (A-delta and C fibers), spinal cord processing pathways, and brain regions associated with pain processing. Pain processing in these species is pharmacologically analogous to human pain — the same drugs (NSAIDs, opioids, local anesthetics, alpha-2 agonists) that relieve human pain are effective in livestock.
Key evidence for livestock pain experience:
Validated pain assessment tools for livestock are essential for identifying animals that need treatment and for evaluating intervention effectiveness. Key developments in 2025:
Animal grimace scales — standardized assessments of facial expression changes associated with pain — have been developed and validated for multiple livestock species:
Grimace scales have transformed clinical pain assessment because they can be applied by farm staff without laboratory equipment. Smartphone apps that automatically score grimace scale images using AI image recognition are in 2025 clinical trials — making point-of-care pain assessment more practical on commercial farms.
The Colorado State University Pain Scale (cattle and horses), the Glasgow Composite Measure Pain Scale (dogs), and species-specific equivalents combine behavioral, physiological, and postural indicators into validated numerical scores. These tools are increasingly required in veterinary training and are used in clinical welfare assessment.
Non-steroidal anti-inflammatory drugs (meloxicam, flunixin, ketoprofen, carprofen) are the most widely used analgesics in livestock. They address both pain and inflammation, making them appropriate for tissue-damage pain (castration, dehorning, lameness). Meloxicam is licensed for cattle and pigs in the EU/UK; flunixin is licensed for cattle. NSAIDs are used off-label for sheep, goats, and poultry in most jurisdictions — a licensing gap that limits uptake. EU revision of the Veterinary Medicinal Products Regulation (2019/6) includes cascade provisions that facilitate off-label NSAID use by veterinarians.
Lidocaine and procaine are widely available for local/regional nerve blocks. Ring blocks (encircling the base of the scrotum in castration) and cornual nerve blocks (base of horn in dehorning) effectively eliminate acute pain during procedures. These are inexpensive, widely available, and have a strong evidence base — the primary barrier to use is skill (injection technique must be learned) and time cost on commercial operations.
Opioids (morphine, butorphanol, buprenorphine) are effective analgesics for severe pain in livestock but are controlled substances requiring veterinary prescription in all jurisdictions. They are used primarily in companion animal medicine and for severe acute pain in large animals. Research on long-acting opioid formulations for livestock is advancing.
Pain management requirements are increasingly embedded in welfare legislation and certification standards:
Despite the science and growing regulatory requirements, significant implementation gaps persist. Surveys consistently find that a large proportion of painful procedures in livestock are still performed without anesthesia or analgesia, even where recommendations or requirements exist. Key barriers: cost, time, veterinary prescription requirements, licensing gaps for some species, and cultural norms ("this is how we've always done it").
Effective interventions to close the gap include: farmer and veterinarian education programs; reduced cost of approved analgesics through government purchasing programs; simplified on-farm analgesia protocols developed collaboratively with industry; assurance scheme certification requirements; and veterinary visit integration (welfare assessment during routine veterinary visits).
A growing economic evidence base shows that pain management pays. Post-operative analgesia in cattle (for dehorning, castration) improves weight gain and feed conversion in the days following the procedure — offsetting the cost of analgesic. Treating lame sheep promptly with both antibiotics and NSAIDs improves treatment success rates compared to antibiotics alone. This "welfare pays" evidence base is a powerful communication tool for producer adoption.
Tags: Livestock Pain Analgesia Welfare Science Assessment 2025